トランスキャセター・ファーストパラダイムへの挑戦: 前回のトランスキャセターまたは外科的な大動脈弁の置換後に再手術
Shinichi Fukuhara1, Carol Ling1, Himanshu J Patel1
1Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan, USA.
The Journal of thoracic and cardiovascular surgery
|August 21, 2025
まとめ
トランスキャテーターによる大動脈弁置換 (TAVR-SAVR) の後の手術による大動脈弁置換は,再手術による大動脈弁置換 (SAVR-SAVR) よりも高い手術死亡率を示しています. TAVR-SAVR戦略は,長期にわたる弁機能を必要とする患者の再検討を正当化します.
科学分野:
- 心血管外科
- 介入心臓科
- 心臓弁 疾患
背景:
- トランスキャテーターによる大動脈弁置換 (TAVR) の後,大動脈弁の再手術が増加しています.
- TAVR- SAVRの結果の比較分析は限られている.
- TAVR-SAVRの手続きの臨床結果については懸念があります.
研究 の 目的:
- TAVR (TAVR-SAVR) の後の手術による大動脈弁置換 (SAVR) と,再手術によるSAVR (SAVR-SAVR) の臨床結果を比較する.
- 動脈弁の再手術の傾向を分析する
- 異なる大動脈弁再手術戦略の安全性と有効性を評価する.
主な方法:
- 2011年から2024年の間にTAVRまたはSAVRを受けた1,024人の患者群が特定されました.
- 参加した患者は,孤立したSAVR±冠動脈バイパス移植 (CABG) を受けた.
- TAVR-SAVRとSAVR-SAVRグループのアウトカムを比較するために,傾向スコアマッチングを使用した.
主要な成果:
- 2024年までに大動脈弁再手術におけるTAVR-SAVRの割合は31.3%に上昇した.
- TAVR- SAVRの患者は高齢で,併発症率が高く,心不全の負担が大きかった.
- TAVR- SAVRでは,傾向スコアが一致しても,手術後の死亡率 (12. 3% 対 1. 1%, p< 0. 001) と複合合併症率が著しく高かった.
結論:
- TAVR-SAVRの症例は増加しており,2029年までにSAVR-SAVRを上回る可能性があります.
- SAVR-SAVR戦略は極めて安全で,観察された死亡率と予想される死亡率の比率が低いことが示されました.
- TAVRを優先する戦略は,特に TAVR義肢の耐久性より長生きする患者の場合,再検討が必要である.
関連する概念動画
Aortic Regurgitation III: Medical Management
42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Aneurysm IV: Nursing Management
20
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
20
Aneurysm III: Interprofessional Care
24
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52


